Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-07-31
DOI
10.1038/s41598-018-30168-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma
- (2016) Arezoo Rasti et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma
- (2015) Carla Micucci et al. BRITISH JOURNAL OF CANCER
- Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes
- (2015) Raheleh Roudi et al. CANCER INVESTIGATION
- Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling
- (2015) Xin Yin et al. Journal of Hematology & Oncology
- Expressions of stem cell transcription factors Nanog and Oct4 in renal cell carcinoma tissues and clinical significance
- (2015) Bin Yu et al. Artificial Cells Nanomedicine and Biotechnology
- The Differential Expression of OCT4 Isoforms in Cervical Carcinoma
- (2015) Shao-Wen Li et al. PLoS One
- The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
- (2013) John R. Srigley et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis
- (2013) Monireh Mohsenzadegan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts
- (2013) Alexandre Ingels et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostication of OCT4 isoform expression in prostate cancer
- (2013) Marina França de Resende et al. TUMOR BIOLOGY
- High Expression of Stem Cell Marker ALDH1 is Associated with Reduced BRCA1 in Invasive Breast Carcinomas
- (2012) Zahra Madjd et al. Asian Pacific Journal of Cancer Prevention
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
- (2012) Juanjuan Shan et al. HEPATOLOGY
- Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
- (2012) S M Kumar et al. ONCOGENE
- Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas
- (2011) Yuji Guo et al. HISTOPATHOLOGY
- Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer
- (2010) Hui-Min Meng et al. CANCER BIOLOGY & THERAPY
- Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell-Like Properties and Epithelial-Mesenchymal Transdifferentiation
- (2010) S.-H. Chiou et al. CANCER RESEARCH
- Oct4 and Nanog Expression Is Associated With Early Stages of Pancreatic Carcinogenesis
- (2010) Jing Wen et al. PANCREAS
- Functional Evidence that the Self-Renewal GeneNANOGRegulates Human Tumor Development
- (2009) Collene R. Jeter et al. STEM CELLS
- Octamer 4 Small Interfering RNA Results in Cancer Stem Cell-Like Cell Apoptosis
- (2008) T. Hu et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started